TM Bioscience
Toronto, Ontario, Canada
About TM Bioscience
Tm Bioscience Corporation, a DNA-based diagnostics company, engages in developing a suite of genetic tests principally in Canada and the United States. Its product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease. The company's primary product includes Tag-It Mutation Detection Kit for the P450-2D6 drug metabolism gene; Tag-It CFTR 40+4 mutation detection kit detecting 40 mutations and 4 variants in the Cystic Fibrosis gene; and a custom developed Cystic Fibrosis CFTR 70 test for specialty laboratories.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $13.0M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2006)
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/tm-bioscience-2490842 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.